TESTING STATISTICAL HYPOTHESES OF EQUIVALENCE AND NONINFERIORITY: SECOND EDITION

Testing Statistical Hypotheses of Equivalence and Noninferiority: Second Edition

Volumn , Issue , 2010, Pages 1-403

  Wellek, Stefan ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85152844632     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/EBK1439808184     Document Type: Book

References (206)

1. Abramowitz, M. and Stegun, I. (1965) Handbook of Mathematical Functions. New York: Dover Publications, Inc.
2. Agresti, A. (2002) Categorical Data Analysis. Second Edition. Hoboken, NJ:John Wiley and Sons, Inc.
3. Altman, D.G. and Bland, J.M. (1995) Absence of evidence is not evidence of absence. British Medical Journal 311: 485.
4. Andersen, P.K., Borgan, O., Gill, R.D. and Keiding, N. (1993) Statistical Models Based on Counting Processes. Berlin: Springer-Verlag.
5. Andersen, P.K. and Gill, R.D. (1982) Cox’s regression model for counting processes: A large sample study. Annals of Statistics 10: 1100-20.
6. Anderson, S. and Hauck, W.W. (1983) A new procedure for testing equivalence in comparative bioavailability and other clinical trials. Communications in Statistics: Theory and Methods 12: 2663-92.
7. Anderson, S. and Hauck, W.W. (1990) Consideration of individual bioequivalence. Journal of Pharmacokinetics and Biopharmacology 18: 259-73.
8. Anderson, T.W. (1984) An Introduction to Multivariate Statistical Analysis. Second Edition. New York: John Wiley and Sons, Inc.
9. Armitage, P. (1955) Tests for linear trends in proportions and frequencies. Biometrics 11: 375-86.
10. Bailey, C.C., Gnekow, A., Wellek, S., Jones, M., Round, C., Brown, J., Philips, A. and Neidhardt, M.K. (1995) Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology SIOP and the German Society of Paediatric Oncology GPO: SIOP II. Medical Pediatric Oncology 25: 166-78.
11. Barnard, G.A. (1947) Significance tests for 2x2 tables. Biometrika 34: 123-38.
12. Berger, J.O. (1985) Statistical Decision Theory and Bayesian Analysis. Second Edition. New York: Springer-Verlag.
13. Berger, R.L. (1982) Multiparameter hypothesis testing and acceptance sampling. Technometrics 24: 295-300.
14. Berger, R.L. and Boos, D.D. (1994) P values maximised over a confidence set for the nuisance parameter. Journal of the American Statistical Association 89: 1012-16.
15. Berger, R.L. and Hsu, J.C. (1996) Bioequivalence trials, intersection-union tests and equivalence confidence sets. Statistical Science 11: 283-319.
16. Berger, R.L. and Sidik, K. (2003) Exact unconditional tests for a 2×2 matched pairs design. Statistical Methods in Medical Research 12: 91-108.
17. Bickel, P.J. and Doksum, K.A. (2001) Mathematical Statistics: Basic Ideas and Selected Topics. Vol. I. Second Edition. Upper Saddle River, NJ:Prentice Hall.
18. Bishop, Y.M.M., Fienberg, S.E. and Holland, P.W. (1975) Discrete Multivariate Analysis: Theory and Practice. Cambridge, MA: MIT Press.
19. Blackwelder, W.C. (1982) “Proving the null hypothesis” in clinical trials. Controlled Clinical Trials 3: 345-53.
20. Blackwelder, W.C. (1993) Sample size and power for prospective analysis of relative risk. Statistics in Medicine 12: 691-8.
21. Bondy, W.H. (1969) A test of an experimental hypothesis of negligible difference between means. The American Statistician 23: 28-30.
22. Boschloo, R.D. (1970) Raised conditional level of significance for the 2 × 2- table when testing the equality of two probabilities. Statistica Neerlandica 24: 1-35.
23. Box, G.P.E. and Tiao, G.C. (1973) Bayesian Inference in Statistical Analysis.Reading, MA: Addison-Wesley.
24. Brown, B.W. (1980) The crossover experiment for clinical trials. Biometrics 36: 69-79.
25. Brown, L.D., Hwang, J.T.G. and Munk, A. (1997) An unbiased test for the bioequivalence problem. Annals of Statistics 25: 2345-67.
26. Casella, G. and Berger, R.L. (1987) Reconciling bayesian and frequentist evidence in one-sided testing problems. Journal of the American Statistical Association 82: 106-11.
27. Chan, I.S.F. (1998) Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies. Statistics in Medicine 17: 1403-13.
28. Chan, I.S.F. (2003) Proving non-inferiority or equivalence of two treatments with dichotomous endpoints using exact methods. Statistical Methods in Medical Research 12: 37-58.
29. Chan, I.S.F. and Zhang, Z. (1999) Test-based exact confidence intervals for the difference of two binomial proportions. Biometrics 55: 1202-9.
30. Chen, M.L. (1997) Individual bioequivalence - A regulatory update. Journal of Biopharmaceutical Statistics 7: 5-11.
31. Chester, S.T. (1986) Review of equivalence and hypothesis testing. In ASA Proceedings of the Biopharmaceutical Section. Washington: American Statistical Association, 177-82.
32. Chinchilli, V.M. and Elswick Jr., R.K. (1997) The multivariate assessment of bioequivalence. Journal of Biopharmaceutical Statistics 7: 113-23.
33. Chow, S.C. and Liu, J.P. (2008) Design and Analysis of Bioavailability and Bioequivalence Studies, Third Edition. Boca Raton, FL: Chapman and Hall/CRC Press.
34. Cox, D.R. (1958) Some problems connected with statistical inference. Annals of Mathematical Statistics 29: 357-72.
35. Cox, D.R. and Hinkley, D.V. (1974) Theoretical Statistics. London: Chapman and Hall.
36. D’Angelo, G., Potvin, D. and Turgeon, J. (2001) Carry-over effects in bioequivalence studies. Journal of Biopharmaceutical Statistics 11: 35-43.
37. Dannenberg, O., Dette, H. and Munk, A. (1994) An extension of Welch’s approximate t-solution to comparative bioequivalence trials. Biometrika 81: 91-101.
38. Davies, R. (1971) Rank tests for “Lehmann’s alternative.” Journal of the American Statistical Association 66: 879-83.
39. Davis, P.J. and Rabinowitz, P. (1975) Methods of Numerical Integration. New York: Academic Press.
40. Devlin, B. and Roeder, K. (1999) Genomic control for association studies. Biometrics 55: 997-1004.
41. Dunnett, C.W. and Gent, M. (1977) Significance testing to establish equivalence between treatments, with special reference to data in the form of 2× 2 tables. Biometrics 33: 593-602.
42. EMEA (1998) CPMP/ICH/363/96. http://www.emea.europa.eu/pdfs/human/ich/03636en.pdf9.
43. EMEA (2005) CPMP/EWP/2158/99. http://www.emea.europa.eu/pdfs/human/ewp/21589en.pdf9.
44. Farrington, C.P. and Manning, G. (1990) Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unit relative risk. Statistics in Medicine 9: 1447-54.
45. Feller, W. (1968) An Introduction to Probability Theory and Its Applications. Volume I. Third Edition. New York: John Wiley and Sons, Inc.
46. Feller, W. (1971) An Introduction to Probability Theory and Its Applications. Volume II. Second Edition. New York: John Wiley and Sons, Inc.
47. Firle, E.A. (1998) Asymptotically Distribution-Free Tests for Equivalence for Paired Observations Allowing for Ties. Diploma thesis, Department of Mathematics, University of Mainz, Mainz, Germany.
48. Fisher, R.A. (1934) Statistical Methods for Research Workers. 5th Edition.Edinburgh: Oliver and Boyd.
49. Fluhler, H., Grieve, A.P., Mandallaz, D., Mau, J. and Moser, H. (1983) Bayesian approach to bioequivalence assessment: An example. Journal of Pharmacological Sciences 72: 1178-81.
50. Food and Drug Administration FDA (1997) Bioequivalence Studies-II. Gender Studies with non-replicate Designs. Center for Drug Evaluation and Research at http://www.fda.gov/bioequivdata.
51. Food and Drug Administration FDA (2001) Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. Rockville, MD: Center for Drug Evaluation and Research CDER.
52. Food and Drug Administration FDA (2008) Orange Book, Version 12/2008. http://www.fda.gov/cder/orange/obreadme.htm.
53. Freeman, P. (1989) The performance of the two-stage analysis of two treatment, two period crossover trials. Statistics in Medicine 8: 1421-32.
54. Freitag, G. (2005) Methods for assessing noninferiority with censored data. Biometrical Journal 47: 88-98.
55. Freitag, G., Lange, S. and Munk, A. (2006) Non-parametric assessment of non-inferiority with censored data. Statistics in Medicine 25: 1201-17.
56. Frick, H. (1987) On level and power of Anderson and Hauck’s procedure for testing equivalence in comparative bioavailability trials. Communications in Statistics, Theory and Methods 16: 2771-8.
57. Giani, G. and Finner, H. (1991) Some general results on least favorable parameter configurations with special reference to equivalence testing and the range statistic. Journal of Statistical Planning and Inference 28: 33-47.
58. Giani, G., Strasburger, K. and Seefeldt, F. (2005) SeParATe, Version 3.0B. Diabetesforschungsinstitut an der Heinrich-Heine-Universität, Abt. Biometrie and Epidemiologie, Düsseldorf, Germany.
59. Goddard, K.A.B., Ziegler, A. and Wellek, S. (2009) Adapting the logical basis of tests for Hardy-Weinberg equilibrium to the real needs of association studies in human and medical genetics. Genetic Epidemiology 33: 569-80.
60. Grizzle, J.E. (1965) The two-period change-over design and its use in clinical trials. Biometrics 21: 467-80.
61. Guilbaud, O. (1993) Exact inference about the within-subject variability in 2×2 crossover trials. Journal of the American Statistical Association 88:939-46.
62. Hajek, J., Sidak, Z. and Sen, P.K. (1999) Theory of Rank Tests. San Diego:Academic Press.
63. Hajek, P. and Havranek, T. (1978) Mechanizing Hypothesis Formation. Berlin:Springer-Verlag.
64. Halmos, P.R. (1974) Measure Theory. Berlin: Springer-Verlag.
65. Harkness, W.L. (1965) Properties of the extended hypergeometric distribution. Annals of Mathematical Statistics 36: 938-45.
66. Hauck, W.W. and Anderson, S. (1996) Comment on “Bioequivalence trials, intersection-union tests and equivalence confidence sets.” Statistical Science 11: 303.
67. Hauck, W.W., Hauschke, D., Diletti, E., Bois, F.Y., Steinijans, V.W. and Anderson, S. (1997) Choice of Student’s t- or Wilcoxon-based confidence intervals for assessment of average bioequivalence. Journal of Biopharmaceutical Statistics 7: 179-89.
68. Hauschke, D., Steinijans, V.W. and Diletti, E. (1990) A distribution-free procedure for the statistical analysis of bioequivalence studies. International Journal of Clinical Pharmacology and Therapeutics 28: 72-8.
69. Hauschke, D., Steinijans, V.W. and Hothorn, L.A. (1996) A note on Welch’s approximate t-solution to bioequivalence assessment. Biometrika 83:236-7.
70. Hauschke, D., Steinijans, V.W. and Pigeot, I. (2007) Bioequivalence Studies in Drug Development: Methods and Applications. Chichester: John Wiley and Sons, Inc.
71. Hodges, J.L. and Lehmann, E.L. (1954) Testing the approximate validity of statistical hypotheses. Journal of the Royal Statistical Society, Series B 16: 262-8.
72. Hoffelder, T. (2006) Two-Sample Equivalence Tests for Multivariate Normal Data. Diploma thesis, Department of Mathematics, University of Mainz, Mainz, Germany.
73. Holder, D.J. and Hsuan, F. (1993) Moment-based criteria for determining bioequivalence. Biometrika 80: 835-46.
74. Holzgreve, H., Distler, A., Michaelis, J., Philipp, T. and Wellek, S. (1989) Verapamil versus hydrochlorothiazide for the treatment of hypertension. Results of a long-term double-blind comparative trial. British Medical Journal 299: 881-6.
75. Hotelling, H. (1931) The generalization of Student’s ratio. Annals of Mathematical Statistics 2: 360-78.
76. Hsu, J.C., Hwang, J.T.G., Liu, H.K. and Ruberg, S.J. (1994) Confidence intervals associated with tests for bioequivalence. Biometrika 81: 103-14.
77. Hsueh, H.M., Liu, J.P. and Chen, J.J. (2001) Unconditional exact tests for equivalence or noninferiority for paired binary endpoints. Biometrics 57:478-83.
78. Janssen, A. (1999) Testing nonparametric statistical functionals with application to rank tests. Journal of Statistical Planning and Inference 81:71-93.
79. Janssen, A. (2000) Nonparametric bioequivalence tests for statistical functionals and their efficient power functions. Statistics and Decisions 18:49-78.
80. Janssen, A. andWellek, S. (2008) Exact linear rank tests for two-sample equivalence problems with continuous data. In Technical Report. University of Duesseldorf, Düsseldorf, Germany.
81. Jeffreys, H. (1961) Theory of Probability. Third Edition. Oxford: Clarendon Press.
82. Johnson, A.D. and O’Donnell, C.J. (2009) An open access database of genomewide association results. BMC Medical Genetics 10: 6.
83. Johnson, N.L., Kotz, S. and Balakrishnan, N. (1994) Continuous Univariate Distributions. Volume 1. Second Edition. New York: John Wiley and Sons, Inc.
84. Johnson, N.L., Kotz, S. and Balakrishnan, N. (1995) Continuous Univariate Distributions. Volume 2. Second Edition. New York: John Wiley and Sons, Inc.
85. Johnson, N.L., Kotz, S. and Balakrishnan, N. (1997) Discrete Multivariate Distributions. New York: John Wiley and Sons, Inc.
86. Johnson, N.L., Kotz, S. and Kemp, A.W. (1992) Univariate Discrete Distributions. Second Edition. New York: John Wiley and Sons, Inc.
87. Jones, B. and Kenward, M.G. (1989) Design and Analysis of Cross-Over Trials.London: Chapman and Hall.
88. Jones, B. and Kenward, M.G. (2003) Design and Analysis of Cross-Over Trials. Second Edition. Boca Raton, FL: Chapman and Hall/CRC Press.
89. Kalbfleisch, J.D. and Prentice, R.L. (2002) The Statistical Analysis of Failure Time Data, 2nd Ed. Hoboken, NJ: John Wiley and Sons, Inc.
90. Kallenberg, W.C.M. (1984) Testing Statistical Hypotheses: Worked Solutions.Amsterdam: Centrum voor Wiskunde en Informatica.
91. Karlin, S. (1956) Decision theory for Polya type distributions. Case of two actions, I. In J. Neyman, ed., Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: California University Press., 115-28.
92. Karlin, S. (1957a) Polya type distributions, II. Annals of Mathematical Statistics 28: 281-308.
93. Karlin, S. (1957b) Polya type distributions, III: Admissibility for multi-action problems. Annals of Mathematical Statistics 28: 839-60.
94. Karlin, S. (1968) Total Positivity. Volume 1. Stanford, CA: Stanford University Press.
95. Kingman, J.F.C. and Taylor, S.J. (1973) Introduction to Measure and Probability. Cambridge: Cambridge University Press.
96. Kotz, S., Balakrishnan, N. and Johnson, N.L. (2000) Continuous Multivariate Distributions, Vol. 1: Models and Applications. New York: John Wiley and Sons, Inc.
97. Lachenbruch, P.A. and Lynch, C.J. (1998) Assessing screening tests: extensions of McNemars’s test. Statistics in Medicine 17: 2207-17.
98. Lambert, J.C., Araria-Goumidi, L., Myllykangas, L., Ellis, C., Wang, J.C., Bullido, M.J., Harris, J.M., Artiga, M.J., Hernandez, D., Kwon, J.M., Frigard, B., Petersen, R.C., Cumming, A.M., Pasquier, F., Sastre, I., Tienari, P.J., Frank, A., Sulkava, R., Morris, J.C., St Clair, D., Mann, D.M., Wavrant-DeVrieze, F., Ezquerra-Trabalon, M., Amouyel, P., Hardy, J., Haltia, M., Valdivieso, F., Goate, A.M., Perez-Tur, J., Lendon, C.L. and Chartier-Harlin, M.C. (2002) Contribution of APOE promoter polymorphisms to Alzheimer’s disease risk. Neurology 59: 59-66.
99. Lee, A.J. (1990) U-Statistics. Theory and Practice. New York: Marcel Dekker Inc.
100. Lehmann, E.L. (1963) Nonparametric confidence intervals for a shift parameter. Annals of Mathematical Statistics 34: 1507-12.
101. Lehmann, E.L. (1975) Nonparametrics: Statistical Methods Based on Ranks. San Francisco: Holden-Day, Inc.
102. Lehmann, E.L. (1986) Testing Statistical Hypotheses. Second Edition. New York: John Wiley and Sons, Inc.
103. Lehmann, E.L. and Romano, J.P. (2005) Testing Statistical Hypotheses. Third Edition. New York: Springer.
104. Lindley, D.V. (1970) Introduction to Probability and Statistics from a Bayesian Viewpoint. Part 2: Inference. Cambridge: Cambridge University Press.
105. Little, R.J.A. (1989) Testing the equality of two independent binomial proportions. The American Statistician 43: 283-8.
106. Liu, J.P. and Chow, S.C. (1992) On the assessment of variability in bioavailability/ bioequivalence studies. Communications in Statistics: Theory and Methods 21: 2591-607.
107. Lloyd, C.J. (2008a) A new exact and more powerful unconditional test of no treatment effect from binary matched pairs. Biometrics 64: 716-23.
108. Lloyd, C.J. (2008b) Exact P-values for discrete models obtained by estimation and maximisation. Australian and New Zealand Journal of Statistics 50:329-45.
109. Lloyd, C.J. and Moldovan, M.V. (2008) A more powerful exact test of noninferiority from binary matched pairs data. Statistics in Medicine 27:3540-9.
110. Lu, Y. and Bean, J.A. (1995) On the sample size for one-sided equivalence of sensitivities based upon McNemar’s test. Statistics in Medicine 14:1831-9.
111. MacLeod, M.J., Dahiyat, M.T., Cumming, A.M., Meiklejohn, D., Shaw, D. and St Clair, D. (1999) No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology 53: 418-20.
112. Makuch, R.W. and Simon, R. (1978) Sample size requirements for evaluating a conservative therapy. Cancer Treatment Reports 62: 1037-40.
113. Mandallaz, D. and Mau, J. (1981) Comparison of different methods for decision-making in bioequivalence assessment. Biometrics 37: 213-22.
114. Martín, A.A. (1998) Fisher’s exact and Barnard’s tests. In S. Kotz, C. Reid and D.L. Banks, eds., Encyclopedia of Statistical Sciences, vol. 2. New York: John Wiley and Sons, Inc., 250-8.
115. Mau, J. (1987) On Cox’s confidence distribution. In R. Viertl, ed., Probability and Bayesian Statistics. New York: Plenum., 346-56.
116. Mau, J. (1988) A statistical assessment of clinical equivalence. Statistics in Medicine 7: 1267-77.
117. McDonald, L.L., Davis, B.M., Bauer, H.R. and Laby, B. (1981) Algorithm AS161: critical regions of an unconditional non-randomized test of homogeneity in 2 × 2 contingency tables. Applied Statistics 30: 182-9.
118. McDonald, L.L., Davis, B.M. and Milliken, G.A. (1977) A nonrandomized unconditional test for comparing two proportions in a 2 × 2 contingency table. Technometrics 19: 145-50.
119. McNemar, I. (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12: 153-7.
120. Mehring, G. (1993) On optimal tests for general interval hypotheses. Communications in Statistics, Theory and Methods 22: 1257-97.
121. Mehta, C.R., Patel, N.R. and Tsiatis, A.A. (1984) Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics 40: 819-25.
122. Meredith, M.P. and Heise, M.A. (1996) Comment on “Bioequivalence trials, intersection-union tests and equivalence confidence sets.” Statistical Science 11: 304-6.
123. Metzler, C.M. (1974) Bioavailability - a problem in equivalence. Biometrics 30: 309-17.
124. Miettinen, O. and Nurminen, M. (1985) Comparative analysis of two rates. Statistics in Medicine 4: 213-26.
125. Miller, K.W., Williams, D.S., Carter, S.B., Jones, M.B. and Mishell, D.R. (1990) The effect of olestra on systemic levels of oral contraceptives. Clinical Pharmacology and Therapeutics 48: 34-40.
126. Morgan, W.A. (1939) A test for the significance of the difference between the two variances in a sample from a normal bivariate population. Biometrika 31: 13-9.
127. Morikawa, T., Yanagawa, T., Endou, A. and Yoshimura, I. (1996) Equivalence tests for pair-matched binary data. Bulletin of Informatics and Cybernetics 28: 31-45.
128. Moses, L.E. (1953) Non-parametric methods. In H. Walker and J. Lev, eds., Statistical Inference. New York: Holt, Rinehart and Winston, 426-50.
129. Muller-Cohrs, J. (1988) Size and power of the Anderson-Hauck test and the double t-test in equivalence problems. In Proceedings of the SAS. Copenhagen:European Users Group Internations Conference., 30-8.
130. Munk, A. (1993) An improvement on commonly used tests in bioequivalence assessment. Biometrics 49: 1225-30.
131. Munk, A. (1996) Equivalence and interval testing for Lehmann’s alternative. Journal of the American Statistical Association 91: 1187-96.
132. Nam, J. (1998) Power and sample size for stratified prospective studies using the score method for testing relative risk. Biometrics 54: 331-6.
133. Nam, J. (2006) Non-inferiority of new procedure to standard procedure in stratified matched-pair design. Biometrical Journal 48: 966-77.
134. Nam, J. and Blackwelder, W.C. (2002) Analysis of the ratio of marginal probabilities in a matched-pair setting. Statistics in Medicine 21: 689-99.
135. Neyman, J. and Pearson, E.S. (1936) Contributions to the theory of testing statistical hypotheses I. Unbiased critical regions of type A and type A1. Statistical Research Memoirs 1: 1-37.
136. Patterson, S. and Jones, B. (2005) Bioequivalence and Statistics in Clinical Pharmacology. Boca Raton, FL: Chapman and Hall/CRC Press.
137. Pearson, E.S. (1947) The choice of statistical tests illustrated on their interpretation of data classified in a 2 × 2 table. Biometrika 34: 139-67.
138. Perlman, M.D. and Wu, L. (1999) The emperor’s new tests. Statistical Science 14: 355-69.
139. Pfeiffer, N., Grehn, F., Wellek, S. and Schwenn, O. (1994) Intraocular thymoxamine or acetylcholine for the reversal of mydriasis. German Journal of Ophthalmology 3: 422-6.
140. Philipp, T., Anlauf, M., Distler, A., Holzgreve, H., Michaelis, J. and Wellek, S. (1997) Randomised, double blind multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study. British Medical Journal 315:154-9.
141. Pitman, E.J.G. (1939) A note on normal correlation. Biometrika 31: 9-12.
142. Pratt, J.W. (1960) On interchanging limits and integrals. Annals of Mathematical Statistics 31: 74-7.
143. Racine-Poon, A., Grieve, A.P., Fluhler, H. and Smith, A.F.M. (1987) A twostage procedure for bioequivalence studies. Biometrics 43: 847-56.
144. Randles, R.H. and Wolfe, D.A. (1979) Introduction to The Theory of Nonparametric Statistics. New York: John Wiley and Sons, Inc.
145. Rao, C.R. (1973) Linear Statistical Inference and Its Applications. Second Edition. New York: John Wiley and Sons, Inc.
146. Reich, K., Mossner, R., Konig, I.R., Westphal, G., Ziegler, A. and Neumann, C. (2002) Promoter polymorphisms of the genes encoding tumor necrosis factor-α and interleukin-1β are associated with different subtypes of psoriasis characterized by early and late disease onset. The Journal of Investigative Dermatology 118: 155-63.
147. Richard, F., Fromentin-David, I., Ricolfi, F., Ducimetiere, P., Di Menza, C., Amouyel, P. and Helbecque, N. (2001) The angiotensin I converting enzyme gene as a susceptibility factor for dementia. Neurology 56: 1593-5.
148. Rodary, C., Com-Nougue, C. and Tournade, M.F. (1989) How to establish equivalence between treatments: A one-sided clinical trial in paediatric oncology. Statistics in Medicine 8: 593-8.
149. Rodda, B.E. (1990) Bioavailability: Designs and analysis. In D.A. Berry, ed., Statistical Methodology in the Pharmaceutical Sciences. New York:Marcel Dekker Inc, 57-81.
150. Rodda, B.E. and Davis, R.L. (1980) Determining the probability of an important difference in bioavailability. Clinical Pharmacology and Therapeutics 28: 247-52.
151. Roebruck, P. and Kühn, A. (1995) Comparison of tests and sample size formulae for proving therapeutic equivalence based on the difference of binomial probabilities. Statistics in Medicine 14: 1583-94.
152. Röhmel, J. (2005) Problems with existing procedures to calculate exact unconditional p-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them. Biometrical Journal 47:37-47.
153. Röhmel, J. and Mannsmann, U. (1999a) Unconditional non-asymptotic onesided tests for independent binomial proportions when the interest lies in showing non-inferiority and/or superiority. Biometrical Journal 41:149-70.
154. Röhmel, J. and Mannsmann, U. (1999b) Letter to the editor on “Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies” by S.F. Chan. Statistics in Medicine 18: 1734-5.
155. Romano, J.P. (2005) Optimal testing of equivalence hypotheses. Annals of Statistics 33: 1036-47.
156. Roy, S.N. (1953) On a heuristic method of test construction and its use in multivariate analysis. Annals of Mathematical Statistics 24: 220-38.
157. Sasieni, P.D. (1997) From genotype to genes: Doubling the sample size. Biometrics 53: 1253-61.
158. Savage, I.R. (1956) Contributions to the theory of rank order statistics - the two-sample case. Annals of Mathematical Statistics 27: 590-615.
159. Scaglione, F. (1990) Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis. Current Medical Research and Opinion 12: 25-33.
160. Schall, R. (1995) Assessment of individual and population bioequivalence us ing the probability that bioavailabilities are similar. Biometrics 51: 615-26.
161. Schall, R. and Luus, H.G. (1993) On population and individual bioequivalence. Statistics in Medicine 12: 1109-24.
162. Schoenfeld, D. (1981) The asymptotic properties of nonparametric tests comparing survival distributions. Biometrika 68: 316-9.
163. Schuirmann, D.J. (1987) A comparison of the two one-sided tests procedure and the power approach for assessing equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics 15: 657-80.
164. Schuirmann, D.J. (1996) Comment on “Bioequivalence trials, intersectionunion tests and equivalence confidence sets.” Statistical Science 11: 312-3.
165. Schumann, G., Rujescu, D., Szegedi, A., Singer, P., Wiemann, S., Wellek, S., Giegling, I., Klawe, C., Anghelescu, I., Heinz, A., Spanagel, R., Mann, K., Henn, F.A. and Dahmen, N. (2003) No association of alcohol dependence with a NMDA-receptor 2B gene variant. Molecular Psychiatry 8: 11-2.
166. Searle, S.R. (1987) Linear Models for Unbalanced Data. New York: John Wiley and Sons, Inc.
167. Selwyn, M.R., Dempster, A.P. and Hall, N.R. (1981) A Bayesian approach to bioequivalence for the 2 × 2 changeover design. Biometrics 37: 11-21.
168. Selwyn, M.R. and Hall, N.R. (1984) On Bayesian methods for bioequivalence. Biometrics 40: 1103-8.
169. Sheiner, L.B. (1992) Bioequivalence revisited. Statistics in Medicine 11: 1777-88.
170. Shorack, R. (1967) Tables of the distribution of the Mann-Whitney-Wilcoxon U-statistic under Lehmann alternatives. Technometrics 9: 666-77.
171. Sidik, K. (2003) Exact unconditional tests for testing non-inferiority in matched-pairs design. Statistics in Medicine 22: 265-78.
172. Starks, T.H. (1979) An improved sign test for experiments in which neutral responses are possible. Technometrics 21: 525-30.
173. Steinijans, V.W. and Diletti, E. (1983) Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals. European Journal of Clinical Pharmacology 24: 127-36.
174. Steinijans, V.W. and Diletti, E. (1985) Generalisation of distribution-free confidence intervals for bioavailability ratios. European Journal of Clinical Pharmacology 28: 85-8.
175. Stevens, W.L. (1938) Estimation of blood-group gene frequencies. Annals of Eugenics 8: 362-75.
176. Stuart, A. and Ord, K. (1994) Kendall’s Advanced Theory of Statistics. Volume 1 - Distribution Theory. Sixth Edition. London: Edward Arnold.
177. Suissa, S. and Shuster, J.J. (1985) Exact unconditional sample sizes for the 2 × 2 binomial trial. Journal of the Royal Statistical Society, Series A 148: 317-27.
178. Tango, T. (1998) Equivalence test and confidence interval for the difference in proportions for the paired-sample design. Statistics in Medicine 17:891-908.
179. Ungersböck, K. and Kempski, O.S. (1992) A study of the effect of increased intracranial pressure on the cortical microcirculation of New Zealand white rabbits. Department of Neurosurgery, University of Mainz. Unpubl. Techn. Report.
180. Victor, N. (1987) On clinically relevant differences and shifted nullhypotheses. Methods of Information in Medicine 26: 155-62.
181. Wang, W. (1997) Optimal unbiased tests for equivalence in intrasubject variability. Journal of the American Statistical Association 92: 1163-70.
182. Welch, B.L. (1938) The significance of the difference between means when the population variances are unequal. Biometrika 29: 350-62.
183. Wellek, S. (1990) Vorschläge zur Reformulierung der statistischen Definition von Bioäquivalenz. In G. Giani and R. Repges, eds., Biometrie und Informatik - Neue Wege zur Erkenntnisgewinnung in der Medizin. Berlin:Springer-Verlag, 95-9.
184. Wellek, S. (1991) Zur Formulierung und optimalen Lösung des Bioäquivalenznachweis-Problems in der klassischen Theorie des Hypothesentestens. In J. Vollmar, ed., Bioäquivalenz sofort freisetzender Arzneiformen. Stuttgart: Gustav Fischer Verlag, 91-109.
185. Wellek, S. (1993a) Basing the analysis of comparative bioavailability trials on an individualized statistical definition of equivalence. Biometrical Journal 35: 47-55.
186. Wellek, S. (1993b) A log-rank test for equivalence of two survivor functions. Biometrics 49: 877-81.
187. Wellek, S. (1994) Statistische Methoden zum Nachweis von Aquivalenz.Stuttgart: Gustav Fischer Verlag.
188. Wellek, S. (1996) A new approach to equivalence assessment in standard comparative bioavailability trials by means of the Mann-Whitney statistic. Biometrical Journal 38: 695-710.
189. Wellek, S. (2000a) Bayesian construction of an improved parametric test for probability-based individual bioequivalence. Biometrical Journal 42:1039-52.
190. Wellek, S. (2000b) On a reasonable disaggregate criterion on population bioequivalence admitting of resampling-free testing procedures. Statistics in Medicine 19: 2755-67.
191. Wellek, S. (2004) Tests for establishing compatibility of an observed genotype distribution with Hardy-Weinberg equilibrium in the case of a biallelic locus. Biometrics 60: 694-703.
192. Wellek, S. (2005) Statistical methods for the analysis of two-arm noninferiority trials with binary outcomes. Biometrical Journal 47: 48-61.
193. Wellek, S. and Michaelis, J. (1991) Elements of significance testing with equivalence problems. Methods of Information in Medicine 30: 194-8.
194. Wellek, S., Ziegler, A. and Goddard, K.A.B. (2009) A confidence-limit-based approach to the assessment of Hardy-Weinberg equilibrium. In Technical Report, 2008/9 - 2. Department of Biostatistics, CIMH Mannheim.
195. Westlake, W.J. (1972) Use of confidence intervals in analysis of comparative bioavailability trials. Journal of Pharmacological Sciences 61: 1340-1.
196. Westlake, W.J. (1976) Symmetrical confidence intervals for bioequivalence trials. Biometrics 32: 741-4.
197. Westlake, W.J. (1979) Statistical aspects of comparative bioavailability trials. Biometrics 35: 273-80.
198. Westlake, W.J. (1981) Comments on “Bioequivalence testing - A need to rethink.” Biometrics 37: 591-3.
199. Wiens, B.L. and Iglewicz, B. (1999) On testing equivalence of three populations. Journal of Biopharmaceutical Statistics 9: 465-83.
200. Wiens, B.L. and Iglewicz, B. (2000) Design and analysis of three treatment equivalence trials. Controlled Clinical Trials 21: 127-37.
201. Willems, J.L., Abreu-Lima, C., Arnaud, P., Brohet, C.R., Denis, B., Gehring, J., Graham, I., van Herpen, G. and Machado, H. (1990) Evaluation of ECG interpretation results obtained by computer and cardiologists. Methods of Information in Medicine 29: 308-16.
202. Windeler, J. and Trampisch, H.J. (1996) Recommendations concerning studies on therapeutic equivalence. Drug Information Journal 30: 195-200.
203. Witting, H. (1985) Mathematische Statistik I. Stuttgart: B.G. Teubner.
204. Wittke-Thompson, J.K., Pluzhnikov, A. and Cox, N.J. (2005) Rational inferences about departures from Hardy-Weinberg equilibrium. American Journal of Human Genetics 76: 967-86.
205. Ziegler, A. and König, I.R. (2006) A Statistical Approach to Genetic Epidemiology. Weinheim: Wiley-VCH.
206. Zinner, D.D., Duany, L.F. and Chilton, N.W. (1970) Controlled study of the clinical effectiveness of a new oxygen gel on plaque, oral debris and gingival inflammation. Pharmacology and Therapeutics in Dentistry 1:7-15.